Creative Planning’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.3K Sell
10,485
-780
-7% -$2.37K ﹤0.01% 4028
2025
Q4
$46.9K Buy
11,265
+880
+8% +$4.63K ﹤0.01% 3809
2025
Q3
$44K Buy
+10,385
New +$39.1K ﹤0.01% 3773
2024
Q2
Sell
-24,214
Closed -$57.9K 3109
2024
Q1
$57.9K Hold
24,214
﹤0.01% 2770
2023
Q4
$40.2K Buy
24,214
+4,000
+20% +$7.76K ﹤0.01% 2659
2023
Q3
$38.8K Sell
20,214
-834
-4% -$1.37K ﹤0.01% 2512
2023
Q2
$30.3K Hold
21,048
﹤0.01% 2478
2023
Q1
$44.2K Hold
21,048
﹤0.01% 2363
2022
Q4
$23.8K Hold
21,048
﹤0.01% 2305
2022
Q3
$34K Hold
21,048
﹤0.01% 2145
2022
Q2
$28K Hold
21,048
﹤0.01% 2104
2022
Q1
$34K Buy
21,048
+10,000
+91% +$19.4K ﹤0.01% 2092
2021
Q4
$23K Buy
+11,048
New +$31.5K ﹤0.01% 2034
2017
Q3
Sell
-1,150
Closed -$3K 2572
2017
Q2
$3K Buy
1,150
+1,000
+667% +$2.66K ﹤0.01% 4180
2017
Q1
$0 Sell
150
-338
-69% -$509 ﹤0.01% 4742
2016
Q4
$0 Buy
488
+338
+225% +$300 ﹤0.01% 4689
2016
Q3
$0 Hold
150
﹤0.01% 4630
2016
Q2
$0 Hold
150
﹤0.01% 4405
2016
Q1
$0 Hold
150
﹤0.01% 4397
2015
Q4
$0 Sell
150
-7,667
-98% -$17.6K ﹤0.01% 4466
2015
Q3
$18K Buy
+7,817
New +$18.4K ﹤0.01% 2798
2015
Q2
Sell
-7,817
Closed -$26K 1798
2015
Q1
$26K Buy
7,817
+150
+2% +$536 ﹤0.01% 2509
2014
Q4
$27K Hold
7,667
﹤0.01% 2435
2014
Q3
$39K Hold
7,667
﹤0.01% 2089
2014
Q2
$106K Hold
7,667
﹤0.01% 1396
2014
Q1
$117K Hold
7,667
﹤0.01% 1300
2013
Q4
$62K Hold
7,667
﹤0.01% 1459
2013
Q3
$76K Hold
7,667
﹤0.01% 1282
2013
Q2
$33K Buy
+7,667
New +$31.4K ﹤0.01% 1614

Other funds holding GALT